TPN-101 in Aicardi-Goutières Syndrome (AGS)

NCT05613868 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
4
Enrollment
INDUSTRY
Sponsor class

Stopped Business decision

Conditions

Interventions

Sponsor

Transposon Therapeutics, Inc.